Report Adverse Event

Our Products

Kyowa Kirin International currently has the following medicines available, in different rare disease areas:

Crysvita®

Generic	Therapy Area
Burosumab	Bone Metabolism

Poteligeo®

Generic	Therapy Area
Mogamulizumab	Haemato-oncology

Libmeldy®

Orchard Therapeutics

Generic	Therapy Area
Atidarsagene autotemcel	Cell and Gene Therapy

 Links to more details are available on the European Medicines Agency's website.

ADVERSE EVENTS SHOULD BE REPORTED HERE

Click here to search for Kyowa Kirin’s clinical trials

Press & Media
Careers

Reporting
Responsibility

ABOUT US | CONTACT US | NOTICES | TERMS OF USE

MODERN SLAVERY ACT | THIRD PARTY CODE OF CONDUCT

Dubai:
Kyowa Kirin Pharma FZ-LLC
Office 106, Building 49, Dubai Healthcare City,
Dubai, United Arab Emirates.
PO Box 62468

T: +971 4 581 3700

Riyadh:
Kyowa Kirin Offices
Floor 2, Building 7
Salehiya Trading Company
Abdullah Sulaiman Al Hamdan Street, Sulaimaniya District
Riyadh 11421
Kingdom of Saudi Arabia

Kyowa Kirin International plc is a company registered in Scotland (company number SC198780) with registered address at Galabank Business Park, Galashiels TD1 1QH, United Kingdom.

KKI/GCC/KKI/0067 – June 2025